Alecensaro (alectinib) And The Risk Of Severe Hypertriglyceridemia
ALECENSARO (alectinib), a cancer medication, is being recalled in Canada due to new safety information showing it can cause severe hypertriglyceridemia, a condition where triglyceride levels in the blood become dangerously high. This adverse reaction was identified after the product was already in distribution. The recall affects all ALECENSARO products distributed across Canada.
- Product
- ALECENSARO (alectinib)
- Reason
- New safety information - Product safety - Adverse reaction
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-04-22
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/334b4ebc-5c3a-4312-a9f5-63fbbeeeff2e